Truvada, Gilead’s HIV Prevention drug, has been endorsed by the FDA, the CDC and now New York State Governor, Andrew Cuomo. Cuomo is planning to make New York the first state to include Truvada in its HIV prevention initiative.
The announcement has reinvigorated the debate about whether the drug is empowering or endangering those at risk for the disease. Fusion’s Alicia Menendez sat down with AIDS Foundation of Chicago’s Suraj Madoori and Gawker Staff Writer and Truvada user, Rich Juzwiak to discuss Truvada’s assent in popular opinion, while the drug still remains largely inaccessible to the communities that need it the most.
Credit: Cleo Stiller, Johanna Rojas